Abstract Details

Title NMDA Receptor Autoimmunity in the Absence of Malignancy: A Case Series

Topic Neurotoxicology

Presentation(s) (-)

Poster/Presentation
Number 001

Background

Objective

Design/Methods

Results

Conclusions

Authors/Disclosures
Ged O'Connor, MD (Tallaght Hospital)	No disclosure on file
	No disclosure on file
	No disclosure on file
Jason R. Thonhoff, MD (Houston Methodist Hospital)	Dr. Thonhoff has nothing to disclose.
Colin Doherty, MD	The institution of Dr. Doherty has received research support from UCB pharma. The institution of Dr. Doherty has received research support from Science foundation Ireland.
	No disclosure on file
Orla Hardiman, MD, FRCP, FAAN (Trinity Biomedical Sciences Institute)	Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.